IGF1 and obesity disorder: Among male DIAMOND mice, obesity, hepatomegaly, and MASLD associate with loss in bone anabolic factors from liver (igf1, cyp2r1) and increased expression of suppressors of bone formation (fgf21, ctgf, anxa2).